Inconsistently however, there is study indicated that mesenchymal stem cell (MSC)-derived exosomes can suppress in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells in an miR-100-dependent manner [139]. This evidence concerns the gene VEGFA and breast cancer.